TAHL CINDY
See Remarks
TAHL CINDY has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, TAHL CINDY is listed as See Remarks at FATE THERAPEUTICS INC. Inside the rolling window, TAHL CINDY reported no open-market purchases and 3 open-market sales totaling $155K in FATE. The largest disclosed transaction in the window is a sale of 38,800 FATE shares on Aug 4, 2026, worth $95K.
Companies traded
Other insiders at FATE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$155K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TAHL CINDY made?
TAHL CINDY has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does TAHL CINDY trade?
TAHL CINDY has filed SEC Form 4 disclosures for 1 company, including FATE.
When was TAHL CINDY's most recent SEC Form 4 filing?
TAHL CINDY's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is TAHL CINDY's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, TAHL CINDY is listed as See Remarks.
What is TAHL CINDY's total buy and sell value in the current window?
Inside the rolling retention window, TAHL CINDY bought $0 and sold $155K based on SEC Form 4 filings.
What was TAHL CINDY's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 38,800 FATE shares on 2026-08-04, worth $95K, per SEC Form 4 filings.